mechlorethamine has been researched along with Cancer of Ovary in 31 studies
nitrogen mustard : Compounds having two beta-haloalkyl groups bound to a nitrogen atom, as in (X-CH2-CH2)2NR.
| Excerpt | Relevance | Reference |
|---|---|---|
| " After a median follow-up of more than 6 years following MOPP (mechlorethamine/vincristine/procarbazine/prednisone) chemotherapy with or without radiotherapy, 5% of patients with Hodgkin's disease developed second primaries, 60% of which were leukemias." | 4.78 | Cytotoxic chemotherapy-induced second primary neoplasms: clinical aspects. ( Petru, E; Schmähl, D, 1991) |
| "Besides human 2008 ovarian cancer cells we also found that human lung (A549) and head and neck cancer cells (SCC 25) were transiently sensitized by cisplatin." | 1.29 | Factors influencing the drug sensitization of human tumor cells for in situ lipofection. ( Huang, L; Son, K, 1996) |
| "Of 602 patients treated for non-Hodgkin's lymphomas, 9 developed overt acute nonlymphocytic leukemia or preleukemia with refractory cytopenia and cytogenetic abnormalities of the bone marrow." | 1.27 | Risk of acute nonlymphocytic leukemia and preleukemia in patients treated with cyclophosphamide for non-Hodgkin's lymphomas. Comparison with results obtained in patients treated for Hodgkin's disease and ovarian carcinoma with other alkylating agents. ( Ersbøll, J; Keiding, N; Larsen, MS; Larsen, SO; Nissen, NI; Pedersen-Bjergaard, J; Philip, P; Schultz, H; Sørensen, HM, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 28 (90.32) | 18.7374 |
| 1990's | 3 (9.68) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| ULLERY, JC | 1 |
| MULLER, P | 1 |
| GOLDBERG, G | 1 |
| TOUSSAINT, P | 1 |
| MOORE, JG | 1 |
| BRANDKAMP, WW | 1 |
| BURNES, WL | 1 |
| THEISEN, H | 1 |
| GREEN, TH | 1 |
| COONRAD, EV | 1 |
| RUNDLES, RW | 1 |
| ANKENMAN, GJ | 1 |
| BALFOUR, J | 1 |
| MARK, JB | 1 |
| GOLDENBERG, IS | 1 |
| MONTAGUE, AC | 1 |
| SANSON, J | 1 |
| GRUHN, J | 1 |
| SHINGLETON, WW | 1 |
| PARKER, RT | 1 |
| BROWN, FE | 1 |
| WRIGHT, HK | 1 |
| LATHROP, JC | 1 |
| HRESCHCHYSHYN, MM | 1 |
| CONKLIN, JW | 1 |
| UPTON, AC | 1 |
| CHRISTENBERRY, KW | 1 |
| HORNTRICH, J | 1 |
| MASTERSON, JG | 1 |
| MILLER, SP | 1 |
| BRENNER, SM | 1 |
| ANDERMAN, LB | 1 |
| JOHNSON, WM | 1 |
| HOSMER, F | 1 |
| Cornbleet, MA | 1 |
| Leonard, RC | 1 |
| Smyth, JF | 1 |
| Presant, CA | 1 |
| Carr, D | 1 |
| Son, K | 1 |
| Huang, L | 1 |
| Johnson, LP | 1 |
| Rivkin, SE | 1 |
| Weber, EL | 1 |
| Bruntsch, U | 1 |
| Gallmeier, WM | 1 |
| Kolarić, K | 1 |
| Fuss, V | 1 |
| Maricić, Z | 1 |
| Petru, E | 1 |
| Schmähl, D | 1 |
| Frankfurt, OS | 1 |
| Pedersen-Bjergaard, J | 1 |
| Ersbøll, J | 1 |
| Sørensen, HM | 1 |
| Keiding, N | 1 |
| Larsen, SO | 1 |
| Philip, P | 1 |
| Larsen, MS | 1 |
| Schultz, H | 1 |
| Nissen, NI | 1 |
| Griffen, WO | 1 |
| Humphrey, L | 1 |
| Sosin, H | 1 |
| Smith, JP | 1 |
| Rutledge, F | 1 |
| Anderson, CB | 1 |
| Philpott, GW | 1 |
| Ferguson, TB | 1 |
3 reviews available for mechlorethamine and Cancer of Ovary
| Article | Year |
|---|---|
High-dose alkylating agent therapy: a review of clinical experiences.
Topics: Alkylating Agents; Busulfan; Carcinoma, Bronchogenic; Carmustine; Dose-Response Relationship, Drug; | 1984 |
Cytotoxic chemotherapy-induced second primary neoplasms: clinical aspects.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Hod | 1991 |
The prognosis and management of recurrent abdominal malignancies.
Topics: Abdominal Neoplasms; Adolescent; Adult; Antineoplastic Agents; Bile Duct Neoplasms; Chemotherapy, Ca | 1969 |
28 other studies available for mechlorethamine and Cancer of Ovary
| Article | Year |
|---|---|
Treatment of pelvic malignancy.
Topics: Cobalt; Cobalt Radioisotopes; Female; Gold Radioisotopes; Humans; Mechlorethamine; Neoplasms; Nitrog | 1957 |
[Use of nitrogen mustard derivatives in palliative therapy of genital cancers with special reference to ovarian tumors in advanced stages].
Topics: Female; Genitalia; Genitalia, Female; Humans; Mechlorethamine; Neoplasms; Nitrogen Mustard Compounds | 1958 |
Evaluation of chemotherapy in ovarian and cervical cancer by tissue culture methods.
Topics: Antineoplastic Agents; Busulfan; Female; Humans; Mechlorethamine; Neoplasms; Nitrogen Mustard Compou | 1959 |
[Regression of a metastasizing disgerminoma by cytostatic drug therapy].
Topics: Cytostatic Agents; Dysgerminoma; Female; Humans; Mechlorethamine; Neoplasms; Nitrogen Mustard Compou | 1959 |
Hemisulfur mustard in the palliation of patients with metastatic ovarian carcinoma.
Topics: Antineoplastic Agents; Carcinoma, Ovarian Epithelial; Female; Humans; Mechlorethamine; Mustard Gas; | 1959 |
Mustard chemotherapy in ovarian carcinoma.
Topics: Antineoplastic Agents; Female; Humans; Mechlorethamine; Mustard Plant; Neoplasms; Nitrogen Mustard C | 1959 |
Nitrogen mustard in treatment of metastatic carcinoma of the testis.
Topics: Choriocarcinoma; Dysgerminoma; Female; Humans; Male; Mechlorethamine; Nitrogen Mustard Compounds; Ov | 1961 |
Cases from the medical grand rounds, Case 446 tumor perfusion. Massachusetts General Hospital.
Topics: Female; Hospitals, General; Humans; Massachusetts; Mechlorethamine; Neoplasms; Nitrogen Mustard Comp | 1959 |
INTRAPLEURAL MECHLORETHAMINE HYDROCHLORIDE THERAPY FOR MALIGNANT PLEURAL EFFUSION.
Topics: Breast Neoplasms; Drainage; Female; Humans; Lung Neoplasms; Lymphoma; Mechlorethamine; Neoplasm Meta | 1964 |
SPONTANEOUS ENDOGENOUS CLOSTRIDIAL SEPTICEMIA.
Topics: Antiemetics; Chloramphenicol; Clostridium; Clostridium perfringens; Diabetes Mellitus; Electrocardio | 1964 |
ABDOMINAL PERFUSION FOR CANCER CHEMOTHERAPY USING HYPOTHERMIA AND HYPERTHERMIA.
Topics: Abdomen; Antineoplastic Agents; Chemotherapy, Cancer, Regional Perfusion; Colonic Neoplasms; Cycloph | 1964 |
INTERNAL FLUID SHIFTS SECONDARY TO INTRAPERITONEAL NITROGEN MUSTARD.
Topics: Abdominal Neoplasms; Animals; Body Fluids; Dogs; Female; Fluid Shifts; Hematocrit; Humans; Injection | 1964 |
PERFUSION CHEMOTHERAPY FOR GYNECOLOGICAL MALIGNANCY.
Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Chemotherapy, Cancer, Regional Perfusion; Fallopian Tube N | 1963 |
EXPERIENCES WITH CHEMOTHERAPY IN GYNECOLOGIC CANCER.
Topics: Antineoplastic Agents; Biomedical Research; Chlorambucil; Cyclophosphamide; Dactinomycin; Female; Ge | 1964 |
FURTHER OBSERVATIONS ON LATE SOMATIC EFFECTS OF RADIOMIMETIC CHEMICALS AND X-RAYS IN MICE.
Topics: Aging; Busulfan; Cataract; Female; Humans; Leukemia; Leukemia, Myeloid; Longevity; Lung Neoplasms; L | 1965 |
[Successful therapy of a metastasizing seminoma with nitrogen mustard N-oxide].
Topics: Dysgerminoma; Female; Humans; Male; Mechlorethamine; Neoplasms; Neoplasms, Germ Cell and Embryonal; | 1960 |
The adjuvant chemotherapy study in cancer of the ovary.
Topics: Biomedical Research; Chemotherapy, Adjuvant; Female; Humans; Mechlorethamine; Neoplasms; Nitrogen Mu | 1962 |
Combination therapy with cobalt-60 and chlorambucil in the treatment of disseminated ovarian carcinomatosis.
Topics: Carcinoma; Chlorambucil; Cobalt; Cobalt Radioisotopes; Combined Modality Therapy; Female; Humans; Me | 1962 |
Dysgerminoma treated with nitrogen mustard.
Topics: Dysgerminoma; Female; Humans; Mechlorethamine; Nitrogen Mustard Compounds; Ovarian Neoplasms | 1952 |
Amphotericin B (Fungizone R) enhancement of nitrogen mustard uptake by human tumor cells.
Topics: Amphotericin B; Biological Transport; Carcinoma, Squamous Cell; Carrier Proteins; Cells, Cultured; C | 1980 |
Factors influencing the drug sensitization of human tumor cells for in situ lipofection.
Topics: Animals; Antineoplastic Agents; Bleomycin; Cation Exchange Resins; Chloramphenicol O-Acetyltransfera | 1996 |
Palliation in malignant pleural effusion.
Topics: Adenocarcinoma; Adult; Aged; Breast Neoplasms; Drainage; Female; Hodgkin Disease; Humans; Lung Neopl | 1975 |
[Chemotherapy of the ovarian carcinoma (author's transl)].
Topics: Altretamine; Antineoplastic Agents; Chlorambucil; Cisplatin; Cyclophosphamide; Doxorubicin; Drug The | 1977 |
[Experience with intracavital administration of nitrogen mustard in the treatment of malignant pleural effusions].
Topics: Adult; Aged; Breast Neoplasms; Bronchial Neoplasms; Female; Humans; Male; Mechlorethamine; Middle Ag | 1975 |
Decreased stability of DNA in cells treated with alkylating agents.
Topics: Alkylating Agents; Antibodies, Monoclonal; Antibody Specificity; Deoxyribonucleases; DNA Damage; DNA | 1990 |
Risk of acute nonlymphocytic leukemia and preleukemia in patients treated with cyclophosphamide for non-Hodgkin's lymphomas. Comparison with results obtained in patients treated for Hodgkin's disease and ovarian carcinoma with other alkylating agents.
Topics: Acute Disease; Adolescent; Adult; Aged; Alkylating Agents; Antineoplastic Combined Chemotherapy Prot | 1985 |
Chemotherapy in the treatment of cancer of the ovary.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Cyclophosphamide; Cystadenocarcinoma; Dactinomycin; Female | 1970 |
The treatment of malignant pleural effusions.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Breast Neoplasms; Carcinoma, Small Cell; Carcinoma, Squamou | 1974 |